[Wuding] February 2026 Monthly Revenue NT$178 Million (YoY -12.0%)
NQ Score
62/100
N1 Content Completeness
7
AI Summary (NQ-processed)
Wuding (1733) announced its February 2026 monthly revenue was NT$178 million, a 12.0% decrease compared to the same period last year. As a leading biotech and medical industry player specializing in blood glucose monitoring systems, its revenue performance is related to changes in demand in the global diabetes care market.
AI analysis data is not yet available.